Levels Of Arsenic Compounds Research Articles

SPECIATION OF ARSENIC ACROSS WATER-SEDIMENT INTERFACE OF FALGU RIVER

Two predominant species of arsenic compounds, As(III) and As(V), are found in soils and natural water and they have been classified as carcinogens. The focus of the present study was to examine the speciation of Arsenic (As) across the water-sediment interface at the confluence of drainage for Gaya city and the Falgu River. Gas Chromatography (GC) coupled to Inductively Coupled Plasma Mass Spectrometry (ICP-MS) was used to analyze the organic arsenic species while the inorganic arsenic species, As(III) and As(V), were analyzed by Anion Exchange Chromatography (AEC) coupled with Inductively Coupled Plasma Mass Spectrometry (ICP-MS). The determination of total arsenic load was carried out by colorimetric method using silver diethyldithiocarbamate and was measured at 535 nm. Results revealed that the waters contained Monomethylarsine (MMA), Dimethylarsine (DMA), Trimethylarsine (TMA), As(III) as Arsenite (AsO3-3) and As(V) as Arsenate (AsO4-3). However, the methylated species were found in much higher concentrations in pore water from the sediment as compared to in the free water. The high levels of arsenic compounds found at the drainage sites pose a threat to human health and as such should be monitored and remediated promptly by the local and state governments.

8-Hydroxy-2′-deoxyguanosine and arsenic compounds in urine and serum of a 4-year-old child suffering from acute promyelocytic leukemia during treatment with arsenic trioxide

Arsenic trioxide (ATO) is an effective agent for acute promyelocytic leukemia (APL). In this study, the concentrations of dimethylarsinic acid (DMA), monomethylarsonic acid (MMA), As (V), As (III), and 8-hydroxy-2′-deoxyguanosine (8-OHdG) in urine and/or serum of a 4-year-old APL patient were followed during ATO treatment. In comparison with a similar analysis previously published for an 85-year-old APL patient, the levels of arsenic compounds and the percentages of MMA and DMA in the present child patient were lower than those of the old patient. Significant positive correlation of 8-OHdG was observed only with DMA, and not with other arsenic compounds. These results are quite different from those of our previous study on an old APL patient during ATO treatment. When arsenic poisoning is diagnosed, it seems important to take into account the differences in the arsenic metabolism according to the ages of subjects. This study is the first to show the relationship between the levels of 8-OHdG and arsenic compounds in urine of a child APL patient treated with ATO.

8-Hydroxy-2′-deoxyguanosine (8-OHdG) as a possible marker of arsenic poisoning: a clinical case study on the relationship between concentrations of 8-OHdG and each arsenic compound in urine of an acute promyelocytic leukemia patient being treated with arsenic trioxide

Arsenic trioxide (ATO) is an effective therapeutic agent for acute promyelocytic leukemia (APL). In the present study, the concentrations of 8-hydroxy-2′-deoxyguanosine (8-OHdG) and arsenic compounds [(dimethylarsinic acid (DMA), monomethylarsonic acid (MMA), As(V), and As(III)] in urine of an APL patient were determined during ATO treatment. The concentrations of 8-OHdG, DMA, and MMA were increased, especially during the fi rst consolidation therapy. Signifi cant positive correlations were observed between concentrations of 8-OHdG and DMA, between concentrations of 8-OHdG and MMA, and between concentrations of 8-OHdG and the sum of arsenic compounds. The present study supports the idea that urinary 8-OHdG can be a marker for arsenic poisoning, when it is detected together with DMA and MMA. In addition, this study is the fi rst to show the relationship between 8-OHdG and levels of arsenic compounds in urine of an APL patient being treated with ATO.